Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Hematologic Oncology

Breast Cancer

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Hematologic Oncology

FDA Approves Fedratinib for Myelofibrosis

The FDA has approved fedratinib (Inrebic) for the treatment of adult patients with intermediate-2 or high-risk primary or secondary myelofibrosis.
Read More >>

AML Findings Suggest a Broader Role for Genomic Testing

CML Paradigm Transforms With New Treatments, Potential for TKI Discontinuation

NCCN Guidelines Set New Pace for Pediatric ALL

Targeted Agents Transforming AML Paradigm

FDA Approves Rituximab Biosimilar for CD20+ B-Cell Non-Hodgkin Lymphoma and CLL

View More Stories >>

View Conference Coverage

Charlotte Plasma Cell Disorder Congress

State of the Science Summit on Breast Cancer in Long Island

2019 International Lung Cancer Congress

2019 State of the Science Summit on Genitourinary Cancers in Jacksonville

2019 State of the Science Summit on Hematologic Malignancies in Pittsburgh

Dr. Rossetti on Risk Stratification in Myeloproliferative Neoplasms

Dr. Zain on Investigational Approaches in Peripheral T-Cell Lymphoma

Dr. Mesa on the FDA Approval of Fedratinib in Myelofibrosis

Dr. Pullarkat on Treatment Strategies in Transplant Ineligible ALL

Dr. Snyder on Mainstays of Treatment in Polycythemia Vera

Dr. Chao on Minimal Residual Disease in ALL

OncLive houses thousands of videos that provide updates and information.
See more Videos

Treating Relapse in Follicular Lymphoma

Follicular Lymphoma: Progression of Disease

Role of Hypomethylating Agents in AML

Treatment of AML With Myelodysplasia-Related Changes

Maintenance Therapy for Follicular Lymphoma

$Selection of a BTK Inhibitor in Relapsed/Refractory MCL$

OncLive houses thousands of videos that provide updates and information.
See more Videos

Treating Follicular Lymphoma: Addressing Unmet Needs

$Treating Relapsed/Refractory Follicular Lymphoma$

Treating Relapsed/Refractory Follicular Lymphoma

Obinutuzumab Versus Rituximab in Frontline FL

FL: Interpreting and Applying GALLIUM Data in Practice

Using BTK Inhibitors in Community Practice

BTK Combination Strategies for B-Cell Malignancies

BTK Inhibitors in Chronic Lymphocytic Leukemia

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Therapeutic Inhibition of XPO1-Mediated Nucleocytoplasmic Transport With SINE Technology

Cancer is a complex disease characterized by uncontrolled cell growth and metastatic dissemination of tumor cells. View Now

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma. View Now

Featured Video

Dr. Richardson Discusses New Directions in Multiple Myeloma

Paul G. Richardson, MD, clinical program leader and director of clinical research, Jerome Lipper Multiple Myeloma Center, and institute physician, Dana-Farber Cancer Institute, discusses new directions in multiple myeloma. View now

Priority Review Designation in GIST, Promising Findings in Bladder Cancer and NSCLC, and More